PlainPharmaWatch

CMS Open Payments · Program Year 2024

Phadia AB

Phadia AB reported $36,873.10 across General Payments, Research, and Ownership to 14 physicians and teaching hospitals across 15 transactions.

$36.9K
All-tracks total
15
Transactions
14
Recipients
+$10.4K
General Payments vs PY2023

Phadia AB reported $36,873.10 across all CMS Open Payments tracks (General + Research + Ownership) to 14 physicians and teaching hospitals in Program Year 2024 - ranking #1420 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,873.10, averaging $2.6K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer phadia-ab Phadia AB

$36.9K · #1420/1,925 · 0.0% industry · PY2024

  • TOT $36.9K
  • RANK #1420
  • SHARE 0.0%
  • TXN 15
  • RCP 14
  • CAT 2
  • GEN $11.9K
  • ΔGEN +$10.4K
  • TOP1 35.6%
  • PY 2024

Nearest volume peer: Crossroads Orthopedics, LLC ($36.8K)

Sensible Medical Innovations…$37.1KPhadia AB (this)$36.9KCrossroads Orthopedics, LLC$36.8KConetic Solutions, Inc.$36.7KNucletron B.V.$36.7K
All-tracks payment totals near Phadia AB (CMS Open Payments PY2024)

Phadia AB sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Phadia AB's CMS-reported General Payments increased by $10.4K (+691.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: PHADIA ABPY2023: PHADIA ABPY2024: Phadia AB. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.5KPY2024$11.9K
PY2023
$1,500.00
PY2024
$11,873.10

What the Data Shows for Phadia AB

Phadia AB ranks #1420 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $36,873.10 across 15 transactions to 14 physicians and teaching hospitals - $2.5K per transaction and $2.6K per recipient on average.

Of the 2 general-payment categories charted below, "Travel and Lodging" is the largest at $11.7K across 12 transactions, 98.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Phadia AB's largest category was "Travel and Lodging" at $11.7K - 98.8% of General Payments.

How Phadia AB divides its payments

General-payment categories, ordered by reported total

1. Travel and Lodging$11.7K2. Food and Beverage$144.83
Payment Type Amount Transactions
Travel and Lodging $11.7K 12
Food and Beverage $144.83 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $11,873.10 (100.0%) of $11,873.10 in this company's General Payments records across 4 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Phadia AB

The five named recipients with the highest reported General Payments from this company

Lee Hilborne$4.2KRenee Sullivan$3.2KHolly Hilsenbeck$3.0KNathan Richards$1.4K
  1. 1

    Lee Hilborne

    $4,226.34 across 3 reported transactions

  2. 2

    Renee Sullivan

    $3,202.98 across 3 reported transactions

  3. 3

    Holly Hilsenbeck

    $3,002.61 across 3 reported transactions

  4. 4

    Nathan Richards

    $1,441.17 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Phadia AB's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Phadia AB.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Phadia AB.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Phadia AB's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.